Optima Medical Innovations Corp.
TOKIF
$0.00
$0.000.00%
| 09/30/2021 | 06/30/2021 | ||||
|---|---|---|---|---|---|
| Revenue | 20.04% | -20.08% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 20.04% | -20.08% | |||
| Cost of Revenue | 24.73% | -23.62% | |||
| Gross Profit | 8.63% | -9.92% | |||
| SG&A Expenses | 147.63% | -75.92% | |||
| Depreciation & Amortization | -4.14% | 3.01% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 38.15% | -33.78% | |||
| Operating Income | -57,433.33% | 99.88% | |||
| Income Before Tax | -966.45% | 138.89% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -966.45% | 138.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -966.45% | 138.89% | |||
| EBIT | -57,433.33% | 99.88% | |||
| EBITDA | -148.00% | 192.15% | |||
| EPS Basic | -966.67% | 140.00% | |||
| Normalized Basic EPS | -900.00% | 140.00% | |||
| EPS Diluted | -966.67% | 140.00% | |||
| Normalized Diluted EPS | -900.00% | 140.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
